Celanese Announces Acetyl Intermediates Price Increases

DALLAS & AMSTERDAM--(BUSINESS WIRE)-- Celanese Corporation (NYSE: CE), a global specialty materials company, will increase list and off-list selling prices for the following acetyl intermediate products. The price increases below will be effective for orders shipped on or after October 1, 2018, or as contracts otherwise allow, and are incremental to any previously announced increases.

About Celanese

Celanese Corporation is a global technology leader in the production of differentiated chemistry solutions and specialty materials used in most major industries and consumer applications. Our businesses use the full breadth of Celanese's global chemistry, technology and commercial expertise to create value for our customers, employees, shareholders and the corporation. As we partner with our customers to solve their most critical business needs, we strive to make a positive impact on our communities and the world through The Celanese Foundation. Based in Dallas, Celanese employs approximately 7,700 employees worldwide and had 2017 net sales of $6.1 billion. For more information about Celanese Corporation and its product offerings, visit www.celanese.com or our blog at www.celaneseblog.com.

All registered trademarks are owned by Celanese International Corporation or its affiliates.

View source version on businesswire.com: https://www.businesswire.com/news/home/20180926005676/en/

Celanese
Investor Relations
Surabhi Varshney, +1-972-443-3078
[email protected]
or
Media Relations – Global
W. Travis Jacobsen, +1-972-443-3750
[email protected]
or
Media Relations Asia (Shanghai)
Helen Zhang, +86 21 3861 9279
[email protected]
or
Media Relations Europe (Germany)
Jens Kurth, +49(0)69 45009 1574
[email protected]

Source: Celanese Corporation

You May Also Be Interested In

• Celanese and Vigor sign deal for plastic robot joints
• VIGOR and Celanese Sign Strategic Partnership Agreement
• From Caregiver Perspectives to Clinical Trial Design: Advancing Community-Engaged Autism Research